The startup develops immunity-boosting proteins using artificial intelligence, immunology, computational biology, and protein engineering to create safe proteins that do not trigger immune responses. This technology enables physicians to prescribe products that are safe for individuals with food allergies and gluten-related disorders.
Funding
$59.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LBFounders
Product
Problem
Millions suffer from food allergies and sensitivities, leading to significant healthcare costs and social impact. Current approaches often fail to provide comprehensive solutions, leaving many individuals with limited options for managing their conditions.
Solution
Ukko is developing a new class of therapeutics for food allergies and sensitivities by applying computational biology, immunology, and protein engineering. The company leverages an AI-powered platform to map the molecular interactions between allergens and the human immune system. This allows for the design of modified proteins that do not trigger allergic responses but can re-educate the immune system to tolerate the allergen. Ukko's approach aims to modulate the immune system of allergic patients without triggering allergic reactions, offering a novel method for treating life-threatening allergies and gluten-related disorders.
Target Audience
The primary target audience includes individuals with food allergies, gluten sensitivities, and related disorders, as well as physicians and healthcare providers seeking innovative therapeutic options.
Features
- AI-driven protein design platform for creating hypoallergenic food proteins.
- Clinically validated mapping of allergen-immune system interactions.
- Development of therapeutics that modulate the immune system without triggering allergic responses.
- Focus on treating life-threatening allergies and gluten-related disorders.
- Computational protein engineering to produce safe proteins.